Cigna Group (NYSE:CI) Issues Quarterly Earnings Results, Beats Estimates By $0.46 EPS

Cigna Group (NYSE:CI) announced its quarterly earnings results on Thursday. The health services provider reported $7.98 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.52 by $0.46, Zacks reports. The business had revenue of $73.79 billion during the quarter, compared to the consensus estimate of $72.64 billion. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The business’s revenue was up 5.6% compared to the same quarter last year. During the same quarter last year, the firm posted $7.83 EPS.

Here are the key takeaways from Cigna Group’s conference call:

• Positive Sentiment: Cigna reported third-quarter adjusted revenue of $73.8 billion and adjusted EPS of $7.98, and raised its 2026 adjusted EPS outlook to at least $30.60.
• Positive Sentiment: Specialty and Care Services earnings grew 15% year over year, supported by specialty pharmacy and distribution capabilities and strong adoption of lower-cost biosimilars and generics. Cigna Healthcare earnings also grew 15%, with medical costs elevated but stable and in line with pricing assumptions.
• Negative Sentiment: Evernorth Pharmacy Benefit Services faces 2027 pressure from industry-wide rebate compression and fewer employers covering GLP-1 drugs for weight loss; management expects PBS earnings to decline by a single-digit percentage. Signature adoption is expected to broaden in 2028, after the Cigna Healthcare fully insured launch in 2027.
• Positive Sentiment: Management expects at least 10% adjusted EPS growth in 2027 from an approximately $30 run-rate base, which reflects the ACA exchange exit and an estimated $200 million headwind. It also reaffirmed its long-term 10%–14% EPS growth framework and at least $45 of adjusted EPS by 2030.
• Positive Sentiment: Cigna expects its Accelerate to One modernization and productivity program to generate $3 billion in gross run-rate savings by 2030, with some savings reinvested in the business and some contributing to results.

Cigna Group Stock Performance

Shares of NYSE CI opened at $293.66 on Friday. The stock has a 50 day moving average price of $285.81 and a 200 day moving average price of $282.17. Cigna Group has a 52 week low of $255.53 and a 52 week high of $318.05. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.76 and a current ratio of 0.76. The stock has a market capitalization of $77.60 billion, a PE ratio of 12.96, a price-to-earnings-growth ratio of 1.00 and a beta of 0.25.

Cigna Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, December 17th. Investors of record on Thursday, December 3rd will be paid a $1.56 dividend. The ex-dividend date of this dividend is Thursday, December 3rd. This represents a $6.24 annualized dividend and a yield of 2.1%. Cigna Group’s payout ratio is currently 25.82%.

Insider Buying and Selling

In other Cigna Group news, insider Everett Neville sold 617 shares of the firm’s stock in a transaction on Thursday, September 3rd. The shares were sold at an average price of $284.05, for a total value of $175,258.85. Following the completion of the transaction, the insider owned 5,053 shares of the company’s stock, valued at approximately $1,435,304.65. This trade represents a 10.88% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Nicole Jones sold 2,677 shares of the business’s stock in a transaction on Tuesday, August 18th. The stock was sold at an average price of $279.61, for a total value of $748,515.97. Following the completion of the transaction, the insider directly owned 25,880 shares of the company’s stock, valued at approximately $7,236,306.80. This trade represents a 9.37% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is currently owned by insiders.

Trending Headlines about Cigna Group

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Third-quarter adjusted earnings were $7.98 per share, ahead of estimates, while revenue rose 6% to about $73.8 billion and also exceeded consensus. Strength in Cigna Healthcare and a favorable pharmacy benefit mix supported results. Cigna Q3 Earnings and Revenues Beat Estimates
• Positive Sentiment: Management raised its 2026 adjusted earnings outlook to at least $30.60 per share. Employer medical growth is expected to help offset Cigna’s exit from the ACA individual market. Cigna lifts 2026 outlook
• Positive Sentiment: At its investor event, Cigna outlined a multi-year $3 billion modernization and productivity program, targeting 10%–14% adjusted EPS growth annually and approximately $50 billion in cumulative operating cash flow through 2030. Cigna raises 2026 outlook after strong quarter
• Neutral Sentiment: Analyst views remain supportive: Cantor Fitzgerald reaffirmed Overweight with a $340 target. Guggenheim kept a Buy rating but lowered its target to $347 from $361, tempering the positive signal. Guggenheim ratings
• Negative Sentiment: Despite higher adjusted earnings, reported GAAP net income fell to $1.4 billion from $1.87 billion a year earlier. The ACA individual-market exit also brings transition and execution risks, even as employer business growth is expected to offset it. Cigna Group lifts outlook as revenue climbs

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on CI shares. Royal Bank Of Canada reissued an “outperform” rating and set a $337.00 price target on shares of Cigna Group in a report on Thursday, October 1st. Raymond James Financial lowered shares of Cigna Group from a “strong-buy” rating to an “outperform” rating and cut their price objective for the company from $350.00 to $320.00 in a research report on Monday, August 3rd. Cantor Fitzgerald restated an “overweight” rating and set a $340.00 price target on shares of Cigna Group in a report on Friday. Jefferies Financial Group downgraded Cigna Group from a “buy” rating to a “hold” rating and lowered their target price for the company from $336.00 to $307.00 in a research report on Tuesday, August 4th. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Cigna Group in a research report on Thursday, August 27th. Fourteen equities research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $335.70.

About Cigna Group

The Cigna Group is a global health services company that provides health insurance and related services through its Cigna Healthcare and Evernorth Health Services businesses. Cigna Healthcare offers medical, dental, behavioral health and other coverage and services to employers, individuals and government-program members.

Evernorth provides pharmacy benefit management, specialty pharmacy, care delivery and other health services. Its offerings include prescription drug benefits and services for people with complex or chronic conditions.

The company serves customers in the United States and select international markets.